What's breaking now, across thousands of outlets.
Alzheon, a biotech that has been attempting to treat Alzheimer's with a checkered drug candidate for more than a decade, is plotting a major fundraise. The Framingham, MA-based biotech outlined an up to $500 million ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Exclusive: FoI documents show senior health officials were warned of concerns about assessment tool weeks after it launched Get our breaking news email , free app or daily news podcast People with…
Exclusive: FoI documents show senior health officials were warned of concerns about assessment tool weeks after it launched Get our breaking news email , free app or daily news podcast People with…
Tinnitus affects millions of people and it can take many different forms. But there are therapies that can help make it more bearable For some it’s a high-pitched mosquito whine; for others it’s a low…
"No single exposure like this is likely, on its own, to meaningfully change an individual child's risk." Don't miss a story, subscribe here.
Transcenta, headquartered in China and with a pipeline of over ten therapeutic antibody candidates, is a clinical-stage biopharmaceutical company with expertise in biologics discovery, translational…
New Medicaid rules use allow use of tiers to determine work exemptions. Advocates fear complex guidelines could cause patients to lose insurance.
